VFA
LH icon

Valeo Financial Advisors’s Labcorp LH Stock Holding History

Valeo Financial Advisors’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.21M Sell
4,335
-351
-7% -$92.3K 0.03% 269
2026
Q1 		$1.25M Sell
4,686
-91
-2% -$24.6K 0.03% 234
2025
Q4 		$1.2M Sell
4,777
-59
-1% -$15.7K 0.03% 264
2025
Q3 		$1.39M Sell
4,836
-2
-0% -$536 0.03% 229
2025
Q2 		$1.27M Sell
4,838
-507
-9% -$123K 0.03% 247
2025
Q1 		$1.24M Sell
5,345
-368
-6% -$89.3K 0.03% 220
2024
Q4 		$1.31M Sell
5,713
-299
-5% -$68.6K 0.04% 202
2024
Q3 		$1.34M Sell
6,012
-1,157
-16% -$254K 0.04% 208
2024
Q2 		$1.46M Sell
7,169
-639
-8% -$130K 0.05% 187
2024
Q1 		$1.62M Buy
7,808
+651
+9% +$143K 0.06% 164
2023
Q4 		$1.63M Sell
7,157
-86
-1% -$18.1K 0.07% 158
2023
Q3 		$1.46M Sell
7,243
-1,049
-13% -$221K 0.07% 156
2023
Q2 		$1.72M Sell
8,292
-955
-10% -$185K 0.08% 137
2023
Q1 		$1.82M Buy
9,247
+906
+11% +$186K 0.09% 138
2022
Q4 		$1.69M Buy
8,341
+18
+0.2% +$3.52K 0.09% 130
2022
Q3 		$1.46M Sell
8,323
-599
-7% -$123K 0.09% 131
2022
Q2 		$1.8M Sell
8,922
-877
-9% -$187K 0.11% 109
2022
Q1 		$2.22M Buy
9,799
+206
+2% +$48.4K 0.11% 110
2021
Q4 		$2.59M Buy
9,593
+48
+0.5% +$11.9K 0.14% 90
2021
Q3 		$2.31M Buy
9,545
+125
+1% +$31.5K 0.13% 104
2021
Q2 		$2.23M Sell
9,420
-6
-0.1% -$1.37K 0.14% 102
2021
Q1 		$2.06M Sell
9,426
-46,938
-83% -$9.42M 0.1% 116
2020
Q4 		$1.61M Buy
56,364
+46,477
+470% +$8.03M 0.08% 122
2020
Q3 		$1.6M Sell
9,887
-1,372
-12% -$217K 0.14% 97
2020
Q2 		$1.61M Buy
11,259
+1,612
+17% +$223K 0.15% 94
2020
Q1 		$1.22M Buy
9,647
+1,292
+15% +$186K 0.13% 104
2019
Q4 		$1.21M Sell
8,355
-202
-2% -$29.2K 0.12% 117
2019
Q3 		$1.24M Buy
8,557
+641
+8% +$93.5K 0.14% 105
2019
Q2 		$1.18M Sell
7,916
-6
-0.1% -$837 0.13% 113
2019
Q1 		$1.04M Buy
7,922
+353
+5% +$43.5K 0.13% 122
2018
Q4 		$822K Buy
7,569
+3,580
+90% +$480K 0.12% 129
2018
Q3 		$550K Buy
3,989
+122
+3% +$18.6K 0.07% 167
2018
Q2 		$597K Sell
3,867
-233
-6% -$35.2K 0.08% 150
2018
Q1 		$570K Sell
4,100
-55
-1% -$8.08K 0.09% 141
2017
Q4 		$569K Buy
4,155
+734
+21% +$97K 0.09% 136
2017
Q3 		$444K Buy
+3,421
New +$456K 0.1% 139

Other funds holding LH

RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
JIC
Johnson Investment Counsel Cincinnati, Ohio $13.7B AUM 21.52% 1-Year Est. Return
BCWM
Bartlett & Co Wealth Management Cincinnati, Ohio $7.99B AUM 20.76% 1-Year Est. Return
AAM
AMI Asset Management Los Angeles, California $1.74B AUM 26.89% 1-Year Est. Return
DIA
Davidson Investment Advisors Great Falls, Montana $2.45B AUM 21.8% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
HPCM
Hunter Perkins Capital Management Lombard, Illinois $446M AUM 25.88% 1-Year Est. Return
MCM
McRae Capital Management Morristown, New Jersey $508M AUM 14.21% 1-Year Est. Return
ET
Equitable Trust Nashville, Tennessee $2.4B AUM 30.76% 1-Year Est. Return

Valeo Financial Advisors's LH Position: Q2 2026 in Review

Valeo Financial Advisors reduced its Labcorp (LH) stake by 7.5% in Q2 2026, selling an estimated $92.3K and leaving 4,335 shares worth $1.21M. The position accounts for 0.03% of the portfolio, ranked #269.

Valeo Financial Advisors first reported a position in LH in Q3 2017 and has held it in 36 quarters since. The position peaked at $2.59M in Q4 2021. 265 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Valeo Financial Advisors held 4,335 shares of Labcorp worth $1.21M as of Q2 2026.
  • Valeo Financial Advisors sold 351 Labcorp shares in Q2 2026, an estimated $92.3K.
  • Labcorp made up 0.03% of Valeo Financial Advisors's portfolio in Q2 2026, its #269 holding.
  • Valeo Financial Advisors first reported a position in Labcorp in Q3 2017 and has held it in 36 quarters since.
  • Valeo Financial Advisors's Labcorp position peaked at $2.59M in Q4 2021.
  • 265 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Valeo Financial Advisors's 13F filing for Q2 2026, filed 8 Jul 2026.